tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
Holding SYRE?
Track your performance easily

Spyre Therapeutics (SYRE) Ownership - Who Owns Spyre Therapeutics?

438 Followers

Spyre Therapeutics (SYRE) Ownership Overview

9.92%16.42%0.06%10.06%63.53%
0.06% Other Institutional Investors
10.06% ETFs
63.53% Public Companies and Individual Investors
The ownership structure of Spyre Therapeutics (SYRE) stock is a mix of institutional, retail, and individual investors. Approximately 26.54% of the company’s stock is owned by Institutional Investors, 9.92% is owned by Insiders, and 63.53% is owned by Public Companies and Individual Investors.
The ownership structure of Spyre Therapeutics (SYRE) stock is a mix of institutional, retail, and individual investors. Approximately 16.48% of the company’s stock is owned by Institutional Investors, 9.92% is owned by Insiders, and 10.06% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 05, 2024
xxxxxxxxxxxxx
$522018

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$7771768
Sep 30, 2024
xxxxxxxxxxxxx
$84481607

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,830,177Insider8.23%100,467,682
4,018,101Institution6.84%83,576,501
2,872,547Institution4.89%59,748,978
2,708,720Institution4.61%56,341,376
2,105,327Institution3.59%43,790,802
1,717,133Institution2.92%35,716,366
1,640,468Institution2.79%34,121,734
1,266,649Institution2.16%26,346,299
959,468Institution1.63%19,956,934
925,293Institution1.58%19,246,094

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,105,327Institution3.59%43,790,802
1,640,468Institution2.79%34,121,734
1,266,649Institution2.16%26,346,299
959,468Institution1.63%19,956,934
910,295Institution1.55%18,934,136
440,587Institution0.75%9,164,210
392,414Institution0.67%8,162,211
314,380Institution0.54%6,539,104
288,785Institution0.49%6,006,728
273,800Institution0.47%5,695,040

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,660,257Institution2.83%47,201,107
924,579Institution1.57%19,231,243
854,276Institution1.46%18,409,648
739,387Institution1.26%21,020,772
310,073Institution0.53%6,449,518
290,845Institution0.50%6,049,576
243,214Institution0.41%5,241,262
162,647Institution0.28%4,624,054
114,931Institution0.20%3,267,488
55,354Institution0.09%1,151,363

FAQ

Who Owns Spyre Therapeutics (SYRE)?
According to the latest TipRanks data, approximately 0.06% of the company's stock is held by institutional investors, 9.92% is held by insiders, and 63.53% is held by retail investors.
    What percentage of Spyre Therapeutics (SYRE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.06% of Spyre Therapeutics (SYRE) stock is held by institutional investors.
      What percentage of Spyre Therapeutics (SYRE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 63.53% of Spyre Therapeutics (SYRE) stock is held by retail investors.
        Who owns the most shares of Spyre Therapeutics (SYRE)?
        Fairmount Funds Management LLC owns the most shares of Spyre Therapeutics (SYRE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis